Novartis Sues Teva Over Premature ANDA Letters
Teva Pharmaceuticals Industries Ltd. jumped the gun in notifying Novartis Corp. that it planned to make generic versions of the Swiss drugmaker's bone treatment Zometa, according to a lawsuit filed Thursday...To view the full article, register now.
Already a subscriber? Click here to view full article